It leads to nearly triple the weight loss of the others in the same time period.

September 2026 Japanese M&A Market Trends and GIP Advisory Track Record."In this webinar, we will explain the trends and notable deals in the Japanese M&A market for the July-September 2026 period, as ...

Despite the major impact of GLP-1 receptor agonists on weight management, post-discontinuation rebound remains a significant ...

Around half a million Australians use GLP-1 medications for diabetes—and when you add people who use them for obesity and ...

Topline Phase 3 results show Eli Lilly’s retatrutide beat Novo’s Ozempic on measures of blood sugar and weight loss in adults ...

In the first head-to-head trial of Ozempic versus Eli Lilly's new "King Kong" drug retatrutide, the next-generation drug led ...

Eating rich holiday foods while taking a drug like Ozempic, Wegovy, Mounjaro, or Zepbound can cause digestive issues. Doctors ...

Eli Lilly’s latest weight loss drug candidate, retatrutide, is already being talked about as a potential game changer in ...

Eli Lilly’s next generation weight loss drug, known as retatrutide, was shown to provide more than double the weight loss of ...

Global Infrastructure Partners, a BlackRock unit, identifies a $100 trillion infrastructure investment opportunity over the next 10-15 years, focusing on energy and power projects.

Fluence Energy is rated buy with a 12-month $9 price target, contingent on resolving Houston plant bottlenecks. Read why FLNC ...

Hello! I'm Newt, a hospital pharmacist!From September 28 to October 2, 2026, the EASD Annual Meeting 2026 was held in Milan, ...